← Back

$ Value

$107K

Shares

11,313

Price

$9

Filed

Mar 5

Insider

Name

Draghia-Akli Ruxandra

Title

EVP, Research & Development

CIK

0002041719

Roles

Officer

Transaction Details

Transaction Date

2026-03-03

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

23,563

Footnotes

Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. | One-third (1/3) of the RSUs subject to this grant under Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the "Plan") vest on each of the first three (3) anniversaries of March 2, 2026, in each case subject to continued employment through such vesting date. | One quarter of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date. | One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date.

Filing Info

Accession No.

0001104659-26-023709

Form Type

4

Issuer CIK

0001000694

Draghia-Akli Ruxandra's History

Date Ticker Type Value
2026-03-03 NVAX M $0
2026-03-03 NVAX F $107K
2026-03-03 NVAX D $0
2026-03-02 NVAX A $0
2026-03-02 NVAX A $0
2025-11-11 NVAX M $0
2025-11-11 NVAX F $45K
2025-11-11 NVAX D $0

Other Insiders at NVAX (90d)

Insider Bought Sold Last
Casey Mark J
EVP, Chief Legal Officer
2026-03-03
Kelly James Patrick
EVP, CFO and Treasurer
2026-03-07
Jacobs John C
President and CEO
2026-03-03
Shiver John W. 2026-03-10
O'Hara Elaine
EVP, Chief Strategy Officer
2026-03-03
Draghia-Akli Ruxandra
EVP, Research & Development
2026-03-03
Walker Robert Edward
EVP, R&D
2026-04-14